Company Description
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States.
The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion.
It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision.
In addition, the company offers Adductoplasty system designed for reproducible correction of metatarsus adductus deformities and osteoarthritis of the midfoot.
It serves physicians, surgeons, ambulatory surgery centers and hospitals related to the surgical management of bunion and related midfoot deformities.
Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
| Country | United States |
| Founded | 2014 |
| IPO Date | Apr 23, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 477 |
| CEO | John Treace |
Contact Details
Address: 100 Palmetto Park Place Ponte Vedra, Florida 32081 United States | |
| Phone | 904 373 5940 |
| Website | treace.com |
Stock Details
| Ticker Symbol | TMCI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $17.00 |
| CIK Code | 0001630627 |
| CUSIP Number | 89455T109 |
| ISIN Number | US89455T1097 |
| Employer ID | 47-1052611 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| John T. Treace | Founder, Chairman and Chief Executive Officer |
| Mark L. Hair CPA | Chief Financial Officer |
| Scot M. Elder J.D. | Chief Legal and Compliance Officer and Corporate Secretary |
| Dr. Sean F. Scanlan Ph.D. | Chief Innovation Officer |
| Gaetano M. Guglielmino | Chief Commercial Officer |
| Terry W. Lubben | Chief Operations and Supply Chain Officer |
| Taylor Erickson | Chief Information and Cybersecurity Officer |
| Brad Barr | Senior Vice President of Sales |
| Daniel E. Owens | Chief Human Resources Officer |
| Shana Zink | Senior Vice President of Clinical Affairs and Reimbursement |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 21, 2025 | 8-K | Current Report |
| May 15, 2025 | SCHEDULE 13G | Filing |
| May 15, 2025 | SCHEDULE 13G/A | Filing |
| May 9, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| May 8, 2025 | 10-Q | Quarterly Report |
| May 8, 2025 | 8-K | Current Report |
| Apr 7, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 7, 2025 | ARS | Filing |
| Apr 7, 2025 | 8-K | Current Report |
| Apr 7, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |